TG101348
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TG101348, covering 2009-10-26 to 2009-10-26. Get the full timeline:
Most recent: Clinical Trial Update: A Dose-escalation Study of the Safety and Tolerability of Orally Administered TG101348 in Patients With Myelofibrosis [Phase 1]